Jul 2026· World Journal of Nephrology· Vol 15· 0 citations· 70 references
Medicine
TL;DR
This paper summarizes the physiological changes associated with LKD surgery, resulting from reduced nephron mass, glomerular hyperfiltration, and blood pressure elevation, to the health risks associated with LKD surgery including chronic kidney disease, proteinuria, hypertension, preeclampsia, adverse psychology, and financial burden.
Abstract
Donor medicine is an emerging field in nephrology. Medical specialties develop from how organ systems organize, new technologies, or groups of diseases. Donor medicine stands at the intersection of medicine, surgery, public health, and the humanities, but unlike recipient medicine does not involve immunology. Living kidney donors (LKDs) start from a position of excellent health and normal predicted lifespan. Nephrologists have a special obligation to follow altruistic LKDs over the long-term, even though the safety of donation has been generally well established. This paper summarizes the physiological changes associated with LKD surgery, resulting from reduced nephron mass, glomerular hyperfiltration, and blood pressure elevation, to the health risks associated with LKD surgery including chronic kidney disease, proteinuria, hypertension, preeclampsia, adverse psychology, and financial burden. Successful kidney transplantation does not simply mean performing a large number of transplants or even achieving a high long-term recipient graft or patient survival rate. Successful kidney transplantation means that the LKD also performs well in a situation that nature never intended for them. Placing long-term donor health into better perspective will help to provide a framework for establishing donor medicine as a distinct medical specialty, which will in turn encourage LKD and increase organ donation rates.
Obesity is a challenging complication that many liver transplant recipients face. Liver transplantation is the sole life-saving procedure in many end-stage liver diseases, but the underlying pathology, in addition to some immunosuppressive regimens, may worsen the metabolic status of many patients. A comprehensive mana...
Soha Elatrebi, R. Abuyadek, S. Abdelbar et al.· World journal of transplanta...· 0 citations
The rising incidence of cancer in kidney transplant patients poses a significant barrier to longterm patient and graft survival. Immunosuppression is a primary component in cancer risk,
although the interaction of recipient characteristics, viral oncogenesis, and donor-related factors
complicates risk assessment. Curre...
Elmukhtar Habas, Amnna Rayani, Aml Habas et al.· Yemen Journal of Medicine· 0 citations
Introduction:
The success of kidney transplantation depends on key factors including appropriate patient selection, satisfactory donor compatibility test, early commencement of immunosuppressant and premedication, good surgical technique with experienced transplant team, intensive post-surgery care, serial daily mon...
Obiatuegwu Kenenna, Aniede Ernest· American Journal of Internal...· 0 citations
Peritoneal dialysis (PD) is recognized as a well-established and safe modality of replacement therapy for patients with end-stage kidney disease. Recently, its use has attracted growing interest as a bridge to kidney transplantation (KTx). Given several advantageous pathophysiological characteristics, such as continuou...
C. Alfieri, F. Tripodi, Luca Nardelli et al.· Kidney360· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.